Highland gets SBIR grant to study Parkinson’s treatment

Bill Edelman, chairman, Highland Instruments

Highland Instruments Inc. has been awarded a Small Business Innovation Research grant over the next few years to study the use of its ElectroSonic Stimulation (ESStim) technology for the treatment of Parkinsons Disease.

Bill Edelman, chairman of the board for Highland, told Mass High Tech only that the grant, through the National Institutes of Health National Institute of Neurological Disorders and Stroke (NIH-NINDS), is substantial, but did not disclose the amount.

The ESStim has been in a Phase 1 trial for the treatment of osteoarthritis pain of the knee since October 2011, said Edelman.

Highland, which was founded in 2007 and operates out of small Boston office, has as its main academic partner in the grant, the Spaulding Rehabilitation Hospitals Laboratory of Neuromodulation in Boston, according to a statement from the company.

Following years of extensive pre-clinical development, I am excited to see the potential benefits of ESStim being brought into the clinic, said Timothy Wagner, Chief Scientific Officer and founder of Highland in a statement. We hope that ESStim will overcome limitations of other reported non-invasive brain stimulation technologies.

Read the original:
Highland gets SBIR grant to study Parkinson’s treatment